Original Source(s)
Related Content
Can Patients Switch to Biosimilar Aflibercept?
A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.
July 20, 2026
-
3 min
Glaucoma in the UK
Largest-ever UK glaucoma patient survey launches to shape future eye care services in the country
July 16, 2026
-
3 min
A Strategic Shift in Vision Healthcare
The clinical and financial imperative for surgical vision correction over conventional optical aids
by Dylan Joseph
July 10, 2026
-
5 min
